Dennis Langer, Director at MYRIAD GENETICS INC (MYGN), sold 30,000 shares at $34.75 ($1.0M) on 2021-08-03, disclosed to the SEC on 2021-08-05.
Open-market sale of $1.0M MYGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DRNA | SELL | 2018-08-17 | $613K | — | Filing → |
| MYGN | SELL | 2018-06-08 | $1.6M | — | Filing → |
| MYGN | SELL | 2018-06-05 | $2.0M | — | Filing → |